This new, intuitive and easy-to-use application has been designed to simplify the entire vaccination process, managing patient vaccine schedules and stock, the administration of vaccines and the prescribing of travel medication. The system also provides healthcare professionals with the most up-to-date travel heath news, alerting users to vaccine contradictions and specific destination health risks.
Incaplex is headquartered at NovaUCD, the Innovation and Technology Transfer Centre, at University College Dublin.
Crevan O'Malley, Helix Health and Richard Boyd, Incaplex
Speaking on the partnership, Crevan O’Malley, Group Commercial Manager, Helix Health said, “We are constantly striving to find new and innovative ways to help our customers deliver enhanced patient care while becoming more efficient and profitable. With the focus of healthcare shifting towards prevention, we feel this new product offering will assist our customers in managing the rising demand for travel vaccinations, backed by growing public awareness.”
“It’s very exciting to see two Irish companies work together in this way,” said Richard Boyd, CEO, Incaplex, “Incaplex is a young company focused on the niche sector of travel medicine using next generation cloud based solutions. Helix leads the market in General Practice and Pharmacy solutions using proven desktop applications. Together we are pointing the way to how healthcare technology can be delivered in the future, a future where healthcare professionals can tailor applications to best suit the needs of their practice and patients.”
ENDS
3 April 2012
For further information contact Micéal Whelan, University College Dublin, Communications Manager (Innovation), e: miceal.whelan@ucd.ie, t: + 353 1 716 3712 or Jennifer Hughes, Corporate Communications Manager, Helix Health Ltd, e: jennifer.hughes@helixhealth.com or t: + 353 1 463 3000.
Editor’s notes
Helix Health is a healthcare ICT market leader currently transforming the Healthcare industry through the delivery of its superior software and IT solutions. The company has been delivering healthcare information systems since 1987 and has grown its footprint in the domestic and overseas market steadily since then. Today Helix Health’s extensive range of cutting-edge technology now empowers more than 10,000 healthcare professionals across Ireland, the United Kingdom and the Middle East to deliver safer, more efficient and cost-effective patient services.
The company is dedicated to providing superior software, hardware, and automated dispensing machines to healthcare professionals including retail and hospital pharmacists, general practitioners, private consultants and numerous specialised healthcare service providers.
In recognition of the company’s commitment to innovation and superior service, Helix Health won the prestigious title of Company of the Year Award at the Software Industry Awards 2010 and was the first Irish Healthcare ICT company to become a Microsoft Gold Certified Partner. www.helixhealth.com
Incaplex is based at NovaUCD, Dublin, Ireland. It is an Enterprise Ireland High Potential Start-Up (HPSU) company. Incaplex was shortlisted by the Irish Software Association for Start-Up of the Year in 2010 and a finalist in the IBM Smartcamp event in London in same year. Incaplex is a Salesforce ISV using the Force.com platform to rapidly build scalable and customisable applications. Incaplex’s first application, Inca Clinic, helps medics to manage their travel vaccination clinics. It simplifies the complexity of creating and managing a patient’s travel itinerary, vaccine schedule, and medication. It currently has customers located in Ireland, UK, South Africa and New Zealand.
The vision of Incaplex is to create an interconnected travel vaccine market using a combination of cloud based and mobile applications that help clinics, travellers and other stakeholders move away from the ad-hoc and fragmented solutions they use today and thereby improving efficiencies and patient care. Incaplex is a trading name of 3Strata Technologies Ltd. www.incaclinic.com
NovaUCD, the Innovation and Technology Transfer Centre, is the hub of innovation and knowledge transfer activities at University College Dublin. NovaUCD is responsible for the commercialisation of intellectual property arising from UCD research and for the development of co-operation with industry and business. NovaUCD as a purpose-built centre also nurtures high-tech and knowledge-intensive enterprises such as Incaplex. NovaUCD has been funded through a unique public-private partnership that includes AIB Bank, Arthur Cox, Deloitte, Enterprise Ireland, Ericsson, Goodbody Stockbrokers, UCD and Xilinx. www.ucd.ie/nova